{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T08:29:52Z","timestamp":1714033792444},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Immigrant Minority Health"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10903-020-01038-x","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T18:03:46Z","timestamp":1591898626000},"page":"1163-1171","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Racial Disparities in Treatment Patterns and Survival Among Surgically Treated Malignant Pleural Mesothelioma Patients"],"prefix":"10.1007","volume":"22","author":[{"given":"Naomi","family":"Alpert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maaike","family":"van Gerwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha","family":"Ohri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Taioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"issue":"11","key":"1038_CR1","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1097\/JTO.0b013e3181f1cf2b","volume":"5","author":"MT Milano","year":"2010","unstructured":"Milano MT, Zhang H. Malignant pleural mesothelioma: a population-based study of survival. J Thorac Oncol. 2010;5(11):1841\u20138.","journal-title":"J Thorac Oncol"},{"key":"1038_CR2","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.21037\/tlcr.2019.11.11","volume":"9","author":"N Alpert","year":"2019","unstructured":"Alpert N, et al. Epidemiology of mesothelioma in the 21st century in Europe and the United States, 40 years after restricted\/banned asbestos use. Transl Lung Cancer Res. 2019;9:S28\u2013S38.","journal-title":"Transl Lung Cancer Res"},{"issue":"2","key":"1038_CR3","first-page":"162","volume":"6","author":"C Bianchi","year":"1997","unstructured":"Bianchi C, et al. Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev. 1997;6(2):162\u20136.","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"1038_CR4","first-page":"70","volume":"12","author":"FE Mott","year":"2012","unstructured":"Mott FE. Mesothelioma: a review. Ochsner J. 2012;12(1):70\u20139.","journal-title":"Ochsner J"},{"key":"1038_CR5","doi-asserted-by":"publisher","first-page":"282145","DOI":"10.1155\/2015\/282145","volume":"2015","author":"E Taioli","year":"2015","unstructured":"Taioli E, et al. Frequency of surgery in Black patients with malignant pleural mesothelioma. Dis Markers. 2015;2015:282145.","journal-title":"Dis Markers"},{"issue":"4","key":"1038_CR6","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1183\/09031936.98.12040972","volume":"12","author":"C Boutin","year":"1998","unstructured":"Boutin C, et al. Malignant pleural mesothelioma. Eur Respir J. 1998;12(4):972\u201381.","journal-title":"Eur Respir J"},{"issue":"4","key":"1038_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/01243894-200605000-00004","volume":"1","author":"RM Flores","year":"2006","unstructured":"Flores RM, et al. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. J Thorac Oncol. 2006;1(4):289\u201395.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"1038_CR8","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1067\/mtc.2002.125817","volume":"124","author":"TT Lee","year":"2002","unstructured":"Lee TT, et al. Radical pleurectomy\/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2002;124(6):1183\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"1038_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11113-016-9416-y","volume":"36","author":"H Sohn","year":"2017","unstructured":"Sohn H. Racial and ethnic disparities in health insurance coverage: dynamics of gaining and losing coverage over the life-course. Popul Res Policy Rev. 2017;36(2):181\u2013201.","journal-title":"Popul Res Policy Rev"},{"issue":"25","key":"1038_CR10","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1200\/JCO.2008.21.7018","volume":"27","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, et al. Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. J Clin Oncol. 2009;27(25):4177\u201381.","journal-title":"J Clin Oncol"},{"issue":"12","key":"1038_CR11","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","volume":"3","author":"DJ Boffa","year":"2017","unstructured":"Boffa DJ, et al. Using the National Cancer Database for outcomes research: a review. JAMA Oncol. 2017;3(12):1722\u20138.","journal-title":"JAMA Oncol"},{"issue":"2","key":"1038_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/1097-0142(19940115)73:2<499::AID-CNCR2820730241>3.0.CO;2-T","volume":"73","author":"GD Steele Jr","year":"1994","unstructured":"Steele GD Jr, et al. The National Cancer Data Base. A mechanism for assessment of patient care. Cancer. 1994;73(2):499\u2013504.","journal-title":"Cancer"},{"issue":"11","key":"1038_CR13","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.jtho.2017.08.012","volume":"12","author":"V Verma","year":"2017","unstructured":"Verma V, et al. National Cancer Database report on pneumonectomy versus lung-sparing surgery for malignant pleural mesothelioma. J Thorac Oncol. 2017;12(11):1704\u201314.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"1038_CR14","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1016\/j.ijrobp.2016.06.323","volume":"96","author":"N Ohri","year":"2016","unstructured":"Ohri N, et al. Definitive radiation therapy is associated with improved survival in non-metastatic malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2016;96(2):S132\u2013S133133.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1038_CR15","unstructured":"Parsons LS. Performing a 1:N Case-control match on propensity score. https:\/\/support.sas.com\/resources\/papers\/proceedings\/proceedings\/sugi29\/165-29.pdf. Accessed July 1 2019."},{"issue":"10","key":"1038_CR16","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1097\/JTO.0b013e3181f1903e","volume":"5","author":"RM Flores","year":"2010","unstructured":"Flores RM, et al. Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population. J Thorac Oncol. 2010;5(10):1649\u201354.","journal-title":"J Thorac Oncol"},{"issue":"12","key":"1038_CR17","doi-asserted-by":"publisher","first-page":"e0145039","DOI":"10.1371\/journal.pone.0145039","volume":"10","author":"E Taioli","year":"2015","unstructured":"Taioli E, et al. Determinants of survival in malignant pleural mesothelioma: a Surveillance, Epidemiology, and End Results (SEER) study of 14,228 patients. PLoS ONE. 2015;10(12):e0145039.","journal-title":"PLoS ONE"},{"issue":"3","key":"1038_CR18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.chest.2017.03.059","volume":"152","author":"S Soneji","year":"2017","unstructured":"Soneji S, et al. Racial and ethnic disparities in early-stage lung cancer survival. Chest. 2017;152(3):587\u201397.","journal-title":"Chest"},{"issue":"3","key":"1038_CR19","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jtho.2016.08.119","volume":"12","author":"E Taioli","year":"2017","unstructured":"Taioli E, Flores R. Appropriateness of surgical approach in Black patients with lung cancer-15 years later, little has changed. J Thorac Oncol. 2017;12(3):573\u20137.","journal-title":"J Thorac Oncol"},{"issue":"4","key":"1038_CR20","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/SLA.0b013e3181b97bac","volume":"250","author":"NF Esnaola","year":"2009","unstructured":"Esnaola NF, et al. Underuse of surgical resection in black patients with nonmetastatic colorectal cancer: location, location, location. Ann Surg. 2009;250(4):549\u201357.","journal-title":"Ann Surg"},{"issue":"4","key":"1038_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cllc.2019.03.003","volume":"20","author":"V Verma","year":"2019","unstructured":"Verma V, et al. Chemotherapy versus supportive care for unresected malignant pleural mesothelioma. Clin Lung Cancer. 2019;20(4):263\u20139.","journal-title":"Clin Lung Cancer"},{"issue":"8","key":"1038_CR22","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1056\/NEJM199902253400806","volume":"340","author":"KA Schulman","year":"1999","unstructured":"Schulman KA, et al. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med. 1999;340(8):618\u201326.","journal-title":"N Engl J Med"},{"issue":"1","key":"1038_CR23","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1186\/s12885-018-5064-4","volume":"18","author":"RM Schwartz","year":"2018","unstructured":"Schwartz RM, et al. Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma. BMC Cancer. 2018;18(1):1188.","journal-title":"BMC Cancer"},{"issue":"11","key":"1038_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.21037\/atm.2017.03.41","volume":"5","author":"RM Schwartz","year":"2017","unstructured":"Schwartz RM, et al. The impact of surgical approach on quality of life for pleural malignant mesothelioma. Ann Transl Med. 2017;5(11):230.","journal-title":"Ann Transl Med"},{"key":"1038_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.lungcan.2017.10.016","volume":"114","author":"MAL Vyfhuis","year":"2017","unstructured":"Vyfhuis MAL, et al. Clinical outcomes of black vs. non-black patients with locally advanced non\u2013small cell lung cancer. Lung Cancer. 2017;114:44\u20139.","journal-title":"Lung Cancer"},{"issue":"4","key":"1038_CR26","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.jtcvs.2018.11.108","volume":"157","author":"A Wolf","year":"2019","unstructured":"Wolf A, et al. Persistence of racial disparities in early-stage lung cancer treatment. J Thorac Cardiovasc Surg. 2019;157(4):1670\u20131679.e1674.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"1038_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/jso.24203","volume":"113","author":"E Taioli","year":"2016","unstructured":"Taioli E, et al. Racial disparities in esophageal cancer survival after surgery. J Surg Oncol. 2016;113(6):659\u201364.","journal-title":"J Surg Oncol"},{"issue":"4","key":"1038_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.cllc.2019.02.015","volume":"20","author":"MAL Vyfhuis","year":"2019","unstructured":"Vyfhuis MAL, et al. Patterns of care and survival in stage III NSCLC among Black and Latino patients compared with White patients. Clin Lung Cancer. 2019;20(4):248\u2013257.e244.","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"1038_CR29","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1016\/j.cllc.2019.08.009","volume":"21","author":"SR Rice","year":"2020","unstructured":"Rice SR, et al. Insurance status is an independent predictor of overall survival in patients with stage III non-small-cell lung cancer treated with curative intent. Clin Lung Cancer. 2020;21(3):e130\u2013e141141.","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"1038_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.lungcan.2013.05.011","volume":"81","author":"J Bauml","year":"2013","unstructured":"Bauml J, et al. Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: do disparities exist? Lung Cancer. 2013;81(3):347\u201353.","journal-title":"Lung Cancer"},{"issue":"2","key":"1038_CR31","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/JTO.0000000000000420","volume":"10","author":"A Bollig-Fischer","year":"2015","unstructured":"Bollig-Fischer A, et al. Racial diversity of actionable mutations in non-small cell lung cancer. J Thorac Oncol. 2015;10(2):250\u20135.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"1038_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/clpt.2014.93","volume":"96","author":"MA Phelps","year":"2014","unstructured":"Phelps MA, et al. Erlotinib in African Americans with advanced non-small cell lung cancer: a prospective randomized study with genetic and pharmacokinetic analyses. Clin Pharmacol Ther. 2014;96(2):182\u201391.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"1038_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/JTO.0b013e3181fb4fe2","volume":"6","author":"JM Reinersman","year":"2011","unstructured":"Reinersman JM, et al. Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African Americans. J Thorac Oncol. 2011;6(1):28\u201331.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"1038_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.lungcan.2005.10.016","volume":"51","author":"A Destro","year":"2006","unstructured":"Destro A, et al. EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations. Lung Cancer. 2006;51(2):207\u201315.","journal-title":"Lung Cancer."},{"issue":"1","key":"1038_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00408-015-9814-7","volume":"194","author":"S Maki-Nevala","year":"2016","unstructured":"Maki-Nevala S, et al. Driver gene and novel mutations in asbestos-exposed lung adenocarcinoma and malignant mesothelioma detected by exome sequencing. Lung. 2016;194(1):125\u201335.","journal-title":"Lung"},{"issue":"9 Supplement","key":"1038_CR36","first-page":"2172","volume":"68","author":"T Takuwa","year":"2008","unstructured":"Takuwa T, et al. Mutation of epidermal growth factor receptor (EGFR) gene in malignant pleural mesothelioma. Cancer Res. 2008;68(9 Supplement):2172\u20132172.","journal-title":"Cancer Res"},{"issue":"5","key":"1038_CR37","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3322\/caac.21572","volume":"69","author":"M Carbone","year":"2019","unstructured":"Carbone M, et al. Mesothelioma: scientific clues for prevention, diagnosis, and therapy. CA Cancer J Clin. 2019;69(5):402\u201329.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1038_CR38","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.pathol.2018.05.002","volume":"50","author":"F Forest","year":"2018","unstructured":"Forest F, et al. Nuclear grading, BAP1, mesothelin and PD-L1 expression in malignant pleural mesothelioma: prognostic implications. Pathology. 2018;50(6):635\u201341.","journal-title":"Pathology"},{"issue":"6","key":"1038_CR39","doi-asserted-by":"publisher","first-page":"259.e259","DOI":"10.1016\/j.urolonc.2015.12.019","volume":"34","author":"DJ Paulucci","year":"2016","unstructured":"Paulucci DJ, et al. BAP1 is overexpressed in black compared with white patients with Mx-M1 clear cell renal cell carcinoma: a report from the cancer genome atlas. Urol Oncol. 2016;34(6):259.e259\u2013.e214.","journal-title":"Urol Oncol"},{"issue":"3","key":"1038_CR40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3322\/canjclin.49.3.145","volume":"49","author":"AM Fremgen","year":"1999","unstructured":"Fremgen AM, et al. Clinical highlights from the National Cancer Data Base, 1999. CA Cancer J Clin. 1999;49(3):145\u201358.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"1038_CR41","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12<2296::AID-CNCR11>3.0.CO;2-P","volume":"80","author":"HR Menck","year":"1997","unstructured":"Menck HR, et al. The growth and maturation of the National Cancer Data Base. Cancer. 1997;80(12):2296\u2013304.","journal-title":"Cancer"}],"container-title":["Journal of Immigrant and Minority Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10903-020-01038-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10903-020-01038-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10903-020-01038-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T23:10:10Z","timestamp":1623366610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10903-020-01038-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1038"],"URL":"https:\/\/doi.org\/10.1007\/s10903-020-01038-x","relation":{},"ISSN":["1557-1912","1557-1920"],"issn-type":[{"value":"1557-1912","type":"print"},{"value":"1557-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,11]]},"assertion":[{"value":"11 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving Human and Animal Rights"}}]}}